Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Montagnese

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Fortschritte Der Neurologie-Psychiatrie|September 25, 2018
[Dystrophic and non-dystrophic myotonias]Federica Montagnese, Benedikt Schoser
Current Opinion in Neurology|May 14, 2021
New developments in myotonic dystrophies from a multisystemic perspectiveFederica Montagnese, Benedikt Schoser
Frontiers in Neurology|May 18, 2018
Core Clinical Phenotypes in Myotonic DystrophiesStephan Wenninger, Federica Montagnese, Benedikt Schoser
Journal of Neurology|March 7, 2019
Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective studyFederica Montagnese, Haris Babačić, Peter Eichhorn, et al.
European Neurology|October 29, 2020
Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2Stephan Wenninger, Kristina Stahl, Federica Montagnese, et al.
Journal of Neurology|December 2, 2020
Non-dystrophic myotonias: clinical and mutation spectrum of 70 German patientsNoemi Vereb, Federica Montagnese, Dieter Gläser, et al.
Clinical Neurology and Neurosurgery|August 26, 2020
Dilative cardiomyopathy displaying double trouble etiology: Myocarditis and Mcleod syndrome?Federica Montagnese, Ulrich Grabmaier, Angela Abicht, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 20, 2016
Long-term whole-body vibration training in two late-onset Pompe disease patientsFederica Montagnese, Simone Thiele, Stephan Wenninger, et al.
Journal of Neurology|October 28, 2019
A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patientsFederica Montagnese, Kristina Stahl, Stephan Wenninger, et al.
Current Opinion in Neurology|July 27, 2018
Towards clinical outcome measures in myotonic dystrophy type 2: a systematic reviewEmanuele Rastelli, Federica Montagnese, Roberto Massa, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Fortschritte Der Neurologie-Psychiatrie|September 25, 2018
[Dystrophic and non-dystrophic myotonias]Federica Montagnese, Benedikt Schoser
Current Opinion in Neurology|May 14, 2021
New developments in myotonic dystrophies from a multisystemic perspectiveFederica Montagnese, Benedikt Schoser
Frontiers in Neurology|May 18, 2018
Core Clinical Phenotypes in Myotonic DystrophiesStephan Wenninger, Federica Montagnese, Benedikt Schoser
Journal of Neurology|March 7, 2019
Evaluating the diagnostic utility of new line immunoassays for myositis antibodies in clinical practice: a retrospective studyFederica Montagnese, Haris Babačić, Peter Eichhorn, et al.
European Neurology|October 29, 2020
Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2Stephan Wenninger, Kristina Stahl, Federica Montagnese, et al.
Journal of Neurology|December 2, 2020
Non-dystrophic myotonias: clinical and mutation spectrum of 70 German patientsNoemi Vereb, Federica Montagnese, Dieter Gläser, et al.
Clinical Neurology and Neurosurgery|August 26, 2020
Dilative cardiomyopathy displaying double trouble etiology: Myocarditis and Mcleod syndrome?Federica Montagnese, Ulrich Grabmaier, Angela Abicht, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 20, 2016
Long-term whole-body vibration training in two late-onset Pompe disease patientsFederica Montagnese, Simone Thiele, Stephan Wenninger, et al.
Journal of Neurology|October 28, 2019
A role for cannabinoids in the treatment of myotonia? Report of compassionate use in a small cohort of patientsFederica Montagnese, Kristina Stahl, Stephan Wenninger, et al.
Current Opinion in Neurology|July 27, 2018
Towards clinical outcome measures in myotonic dystrophy type 2: a systematic reviewEmanuele Rastelli, Federica Montagnese, Roberto Massa, et al.
Pageof 4